2009•China Medical HeraldRequires access

Pharmacokinetics and bioequivalence of Simvastatin Tablets in healthy volunteers

Yinbo Li

Open publisher page 0 citations

Abstract

Objective:To study the pharmacokinetics and bioequivalence of Simvastatin Tablets in Chinese healthy volunteers. Methods:The plasma concentrations of Simvastatin in 20 healthy male volunteers were determined by LC-MS method after being orally administered with single dose of 40 mg Simvastatin Tablets by randomized crossover way;the pharmacokinetic parameters and the relative bioequivalence of the two preparations of Simvastatin were calculated by DAS Ver 2.0 software. Results:The main pharmacokinetic parameters of Simvastatin were as follows:Cmax were(5.58±3.81) and(4.97±2.84) ng/ml;tmax were(1.58±0.49) and(1.93±0.67) h;t1/2 were(5.74±4.55) and(5.75±4.81) h;AUC0-t were(18.40± 11.65) and(19.74±10.53) ng/(h·ml) ;AUC0-∞ were(24.03±18.91) and(26.62±20.05) ng/(h·ml) for the test preparation and the reference preparation,respectively;the 90% confidence interval of AUC0-t,AUC0-∞ and Cmax of the test preparation were 84.2%-99.3%,85.5%-100.8% and 95.9%-121.0%,respectively;the relative bioavailability of Simvastatin was(93.38±18.99) %. Conclusion:The results of the statistic analysis show that the test preparation and the reference preparation of Simvastatin Tablets are bioequivalent.

About this research paper

What this paper is about

Objective:To study the pharmacokinetics and bioequivalence of Simvastatin Tablets in Chinese healthy volunteers. Methods:The plasma concentrations of Simvastatin in 20 healthy male volunteers were determined by LC-MS method after being orally administered with single dose of 40 mg Simvastatin Tablets by randomized crossover way;the pharmacokinetic parameters and the relative bioequivalence of the two preparations of Simvastatin were calculated by DAS Ver 2.0 software. Results:The main pharmacokinetic parameters of Simvastatin were as follows:Cmax were(5.58±3.81) and(4.97±2.84) ng/ml;tmax were(1.58±0.49) and(1.93±0.67) h;t1/2 were(5.74±4.55) and(5.75±4.81) h;AUC0-t were(18.40± 11.65) and(19.74±10.53) ng/(h·ml) ;AUC0-∞ were(24.03±18.91) and(26.62±20.05) ng/(h·ml) for the test preparation and the reference preparation,respectively;the 90% confidence interval of AUC0-t,AUC0-∞ and Cmax of the test preparation were 84.2%-99.3%,85.5%-100.8% and 95.9%-121.0%,respectively;the relative bioavailability of Simvastatin was(93.38±18.99) %. Conclusion:The results of the statistic analysis show that the test preparation and the reference preparation of Simvastatin Tablets are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the pharmacokinetics and bioequivalence of Simvastatin Tablets in Chinese healthy volunteers. Methods:The plasma concentrations of Simvastatin in 20 healthy male volunteers were determined by LC-MS method after being orally administered with single dose of 40 mg Simvastatin Tablets by randomized crossover way;the pharmacokinetic parameters and the relative bioequivalence of the two preparations of Simvastatin were calculated by DAS Ver 2.0 software. Results:The main pharmacokinetic parameters of Simvastatin were as follows:Cmax were(5.58±3.81) and(4.97±2.84) ng/ml;tmax were(1.58±0.49) and(1.93±0.67) h;t1/2 were(5.74±4.55) and(5.75±4.81) h;AUC0-t were(18.40± 11.65) and(19.74±10.53) ng/(h·ml) ;AUC0-∞ were(24.03±18.91) and(26.62±20.05) ng/(h·ml) for the test preparation and the reference preparation,respectively;the 90% confidence interval of AUC0-t,AUC0-∞ and Cmax of the test preparation were 84.2%-99.3%,85.5%-100.8% and 95.9%-121.0%,respectively;the relative bioavailability of Simvastatin was(93.38±18.99) %. Conclusion:The results of the statistic analysis show that the test preparation and the reference preparation of Simvastatin Tablets are bioequivalent.

Key concepts: Bioequivalence, Simvastatin, Medicine, Cmax, Pharmacokinetics, Bioavailability, Confidence interval, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and bioequivalence of Simvastatin Tablets in healthy volunteers — Research Paper | ScholarLens